[Research Report] The rare neurological disease treatment market is expected to reach US$13,830.96 Mn in 2027 from US$ 7,300.12Mn in 2019. The market is estimated to grow with a CAGR of 8.5% from 2020-2027.
Neurological diseases having less diagnostics and treatment options affecting small number of population is termed as rare neurological diseases. These diseases target the nervous system, which include the brain, spinal cord, and all the nerves that run throughout the human body. Amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy, Huntington's disease are few examples of rare neurological conditions. The global rare neurological disease treatment market is driven by factors such as rising prevalence of rare neurological diseases and favorable pipeline drugs and robust research activities for the treatment of rare neurological diseases. However, high treatment cost for rare neurological diseases are likely to show negative impact on market growth during the forecast period.
Lucrative Regional Rare Neurological Disease Treatment Markets
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rising Prevalence of Rare Neurological Diseases
In the world of medicine, rare neurological diseases represent significant burden on health systems in terms of disease diagnosis, treatment, and management. Some of the majorly observed rare neurological diseases comprises narcolepsy, amyotrophic lateral sclerosis, Alzheimer’s disease, multiple sclerosis, spinal muscular atrophy (SMA), Duchenne muscular dystrophy, and others. According to a data published by National Institutes of Neurological Disorders and Stroke in 2019, 7,000 rare neurological diseases have been registered in the US. Additionally, according to the same study, these conditions are responsible for significant number of morbidity and mortality.
Deprivation of sleep, psychological stress, an inherited genetic fault, sudden change in sleep patterns, and aging are the main factors that accelerate the prevalence of rare neurological diseases. Considering these factors, the elderly population is highly vulnerable for neurological conditions. For instance, as per the study published in Annals of Neurology in 2017, around 100 million US populations was affected by the rare neurological disease in 2011. Moreover, these diseases are responsible to increase the morbidity and disability, which affects the economic condition of the country. Neurological sleep related disorders are expected to increase in coming years owing to the increasing ageing population across the world. According to the data published by National Institute of Health (NIH) in 2019, approximately 40 million Americans suffer from neurological diseases in the US, whereas additional 20 million people experience occasional sleeping problems.
Indication Insights
Based on indication, the rare neurological disease treatment market is segmented into narcolepsy, amyotrophic lateral sclerosis, Alzheimer’s disease, multiple sclerosis, spinal muscular atrophy (SMA), Duchene muscular dystrophy, and other indications. The Alzheimer’s disease segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period. The disease accounts for nearly 60% to 80% of all dementia cases and is widely seen among the aging population.
Global Rare Neurological Disease Treatment Market, by Indication – 2018 & 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Drug Type Insights
Based on drug type, the rare neurological disease treatment market is segmented into organic compounds, and biologics. The biologics segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.
Distribution Channel Insights
Based on distribution channel, the rare neurological disease treatment market is segmented into online pharmacies, hospital pharmacies, and retail pharmacies. The hospital pharmacies segment held the largest share of the market in 2019 however, retail pharmacies is estimated to register the highest CAGR in the market during the forecast period.
Mode of Administration Insights
Based on mode of administration, the rare neurological disease treatment market is segmented into oral and injectable. The oral segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Rare Neurological Disease Treatment Market: Strategic Insights
Market Size Value in US$ 7,300.12 Million in 2019 Market Size Value by US$ 13,830.96 Million by 2027 Growth rate CAGR of 8.5% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Rare Neurological Disease Treatment Market: Strategic Insights
| Market Size Value in | US$ 7,300.12 Million in 2019 |
| Market Size Value by | US$ 13,830.96 Million by 2027 |
| Growth rate | CAGR of 8.5% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Product launches and FDA approvals strategy is commonly adopted by companies to expand their footprint worldwide and meet the growing demand. This strategy is most commonly adopted by the market players in order to expand its product portfolio.
The market players operating in the rare neurological disease treatment market adopt the strategy of collaborations to enlarge customer base across the world, which also permits the players to maintain their brand name globally.
Global Rare Neurological Disease Treatment Market– By Indication
- Narcolepsy
- Amyotrophic Lateral Sclerosis
- Alzheimer’s Disease
- Multiple Sclerosis
- Spinal Muscular Atrophy (SMA)
- Duchenne Muscular Dystrophy
- Other Indications
Global Rare Neurological Disease Treatment Market– By Drug Type
- Organic Compounds
- Biologics
Global
Rare Neurological Disease Treatment Market– By Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
Global Rare Neurological Disease Treatment Market – By Mode of Administration
- Oral
- Injectable
Rare Neurological Disease Treatment Market – By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- Allergan plc
- Bayer AG
- GlaxoSmithKline plc
- Johnson & Johnson Services Inc
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd
- Takeda Pharmaceutical
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Indication ; Drug Type ; Distribution Channel ; Mode of Administration and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Rare Neurological Disease Treatment Market– By Indication
1.3.2 Global Rare Neurological Disease Treatment Market– By Drug Type
1.3.3 Global Rare Neurological Disease Treatment Market– By Distribution Channel
1.3.4 Global Rare Neurological Disease Treatment Market – By Mode of Administration
1.3.5 Global Rare Neurological Disease Treatment Market– By Geography
2. Rare Neurological Disease Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Rare Neurological Disease Treatment– Market Landscape
4.1 Overview
4.2 Pest Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East & Africa– PEST Analysis
4.2.5 South and Central America – PEST Analysis
5. Rare Neurological Disease Treatment– Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Rare Neurological Diseases
5.1.2 Favourable Pipeline Drugs and Robust Research Activities for the Treatment of Rare Neurological Diseases
5.2 Key Market Restraints
5.2.1 High Treatment Cost for Rare Neurological Diseases
5.3 Key Market Opportunities
5.3.1 Increasing Awareness of Rare Neurological Diseases Coupled with Developing Healthcare Infrastructure
5.4 Future Trends
5.4.1 Artificial Intelligence for the Treatment of Rare Neurological Diseases
5.5 Impact Analysis
6. Rare Neurological Disease Treatment Market– Global Analysis
6.1 Global Rare Neurological Disease Treatment Market Revenue Forecast And Analysis
6.2 Global Rare Neurological Disease Treatment Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Rare Neurological Disease Treatment Market Analysis – By Indication
7.1 Overview
7.2 Rare Neurological Disease Treatment Market Share, by Indication, 2019 and 2027 (%)
7.3 Narcolepsy
7.3.1 Overview
7.3.2 Narcolepsy: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
7.4 Amyotrophic Lateral Sclerosis
7.4.1 Overview
7.4.2 Amyotrophic Lateral Sclerosis: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
7.5 Alzheimer’s Disease
7.5.1 Overview
7.5.2 Alzheimer’s Disease: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
7.6 Multiple Sclerosis
7.6.1 Overview
7.6.2 Multiple Sclerosis: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
7.7 Spinal Muscular Atrophy (SMA)
7.7.1 Overview
7.7.2 Spinal Muscular Atrophy (SMA): Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Duchenne Muscular Dystrophy
7.8.1 Overview
7.8.2 Duchenne Muscular Dystrophy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
7.9 Other Indications
7.9.1 Overview
7.9.2 Other Indications: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
8. Rare Neurological Disease Treatment Market Analysis – By Drug Type
8.1 Overview
8.2 Rare Neurological Disease Treatment Market Share, by Drug Type, 2019 and 2027, (%)
8.3 Organic Compounds
8.3.1 Overview
8.3.2 Organic Compounds: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Biologics
8.4.1 Overview
8.4.2 Biologics: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
9. Rare Neurological Disease Treatment Market Analysis – By Distribution Channel
9.1 Overview
9.2 Rare Neurological Disease Treatment Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Online Pharmacies
9.3.1 Overview
9.3.2 Online Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Hospital Pharmacies
9.4.1 Overview
9.4.2 Hospital Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Retail Pharmacies
9.5.1 Overview
9.5.2 Retail Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
10. Rare Neurological Disease Treatment Market Analysis – By Mode of Administration
10.1 Overview
10.2 Rare Neurological Disease Treatment Market Share, by Mode of Administration, 2019 and 2027 (%)
10.3 Oral
10.3.1 Overview
10.3.2 Oral: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
10.4 Inject able
10.4.1 Overview
10.4.2 Inject able: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
11. Rare Neurological Disease Treatment Market – Geographic Analysis
11.1 North America: Rare Neurological Disease Treatment Market
11.1.1 Overview
11.1.2 North America: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.1.4 North America: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.1.5 North America: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.1.6 North America: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.1.7 North America: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
11.1.8 US: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.1.8.3 US: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.1.8.4 US: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.1.8.5 US: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.1.9 Canada: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.1.9.3 Canada: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.1.9.4 Canada: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.1.9.5 Canada: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.1.10 Mexico: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.1.10.3 Mexico: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.1.11 Mexico: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.1.11.1 Mexico: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.2 Europe: Rare Neurological Disease Treatment Market
11.2.1 Overview
11.2.2 Europe: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
11.2.3 Europe: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.2.4 Europe: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.2.5 Europe: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.2.6 Europe: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.2.7 Europe: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
11.2.8 Germany: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.8.1 Germany: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.8.2 Germany: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.2.8.3 Germany: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.2.8.4 Germany: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.2.8.5 Germany: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.2.8.6 United Kingdom: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.8.7 United Kingdom: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.8.8 United Kingdom: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.2.8.9 United Kingdom: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.2.8.10 United Kingdom: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.2.8.11 United Kingdom: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.2.9 France: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.9.1 France: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.9.2 France: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.2.9.3 France: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.2.9.4 France: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.2.9.5 France: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.2.10 Spain: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.10.1 Spain: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.10.2 Spain: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.2.10.3 Spain: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.2.10.4 Spain: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.2.10.5 Spain: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.2.11 Italy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.11.1 Italy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.11.2 Italy: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.2.11.3 Italy: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.2.11.4 Italy: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.2.11.5 Italy: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.3 Asia Pacific: Rare Neurological Disease Treatment Market
11.3.1 Overview
11.3.2 Asia Pacific: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
11.3.3 Asia Pacific: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.3.4 Asia Pacific: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.3.5 Asia Pacific: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.3.6 Asia Pacific: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.3.7 Asia Pacific: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
11.3.8 China: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.8.1 China: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.8.2 China: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.3.8.3 China: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.3.8.4 China: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.3.8.5 China: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.3.9 Japan: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.9.1 Japan: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.9.2 Japan: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.3.9.3 Japan: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.3.9.4 Japan: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.3.9.5 Japan: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.3.10 India: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.10.1 India: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.10.2 India: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.3.10.3 India: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.3.10.4 India: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.3.10.5 India: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.3.11 South Korea: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.11.1 South Korea: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.11.2 South Korea: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.3.11.3 South Korea: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.3.11.4 South Korea: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.3.11.5 South Korea: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.3.12 Australia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.13 Australia: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.3.13.1 Australia: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.3.13.2 Australia: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.3.13.3 Australia: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.4 Middle East & Africa: Rare Neurological Disease Treatment Market
11.4.1 Overview
11.4.2 Middle East & Africa: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
11.4.3 Middle East & Africa: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.4.4 Middle East & Africa: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.4.5 Middle East & Africa: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.4.6 Middle East & Africa: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.4.7 Middle East & Africa: Rare Neurological Disease Treatment Market Share by Country – 2019 & 2027, (%)
11.4.8 Saudi Arabia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.4.8.1 Saudi Arabia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.4.8.2 Saudi Arabia: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.4.8.3 Saudi Arabia: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.4.8.4 Saudi Arabia: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.4.8.5 Saudi Arabia: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.4.9 UAE: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.4.9.1 UAE: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.4.9.2 UAE: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.4.9.3 UAE: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.4.9.4 UAE: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.4.9.5 UAE: Rare Neurological Disease Treatment Market, by Distribution Channel , 2018–2027 (USD Million)
11.4.10 South Africa: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
11.4.10.1 South Africa: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.4.10.2 South Africa: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.4.10.3 South Africa: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.4.10.4 South Africa: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.4.10.5 South Africa: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.5 South and Central America: Rare Neurological Disease Treatment Market
11.5.1 Overview
11.5.2 South and Central America: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
11.5.3 South and Central America: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.5.4 South and Central America: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.5.5 South and Central America: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.5.6 South and Central America: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.5.7 South and Central America: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
11.5.8 Brazil: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.5.8.1 Brazil: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.5.8.2 Brazil: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.5.8.3 Brazil: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.5.8.4 Brazil: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.5.8.5 Brazil: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.5.9 Argentina: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.5.9.1 Argentina: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.5.9.2 Argentina: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.5.9.3 Argentina: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.5.9.4 Argentina: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.5.9.5 Argentina: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
12. Impact Of COVID-19 Pandemic On Global Rare Neurological Diseases Treatment Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
13. Rare Neurological Disease Treatment Market –Industry Landscape
13.1 Overview
13.2 Growth Strategies In The Rare Neurological Disease Treatment Market, 2017-2020
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Allergan Plc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bayer AG
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 GlaxoSmithKline plc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Johnson & Johnson Services, Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Merck & Co., Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Novartis AG
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Pfizer Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Sanofi
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Teva Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Takeda Pharmaceutical Company Limited
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. US Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 6. US Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 7. US Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 8. US Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 17. Europe Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 18. Europe Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 19. Europe Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 20. Europe Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 21. Germany Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 22. Germany Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 23. Germany Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 24. Germany Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 25. United Kingdom Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 26. United Kingdom Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 27. United Kingdom Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 28. United Kingdom Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 29. France Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 30. France Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 31. France Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 32. France Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 33. Spain Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 34. Spain Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 35. Spain Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 36. Spain Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 37. Italy Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 38. Italy Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 39. Italy Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 40. Italy Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 41. Asia Pacific Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 42. Asia Pacific Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 43. Asia Pacific Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 44. Asia Pacific Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 45. China Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 46. China Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 47. China Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 48. China Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 49. Japan Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 50. Japan Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 51. Japan Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 52. Japan Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 53. India Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 54. India Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 55. India Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 56. India Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 57. South Korea Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 58. South Korea Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 59. South Korea Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 60. South Korea Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 61. Australia Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 62. Australia Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 63. Australia Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 64. Australia Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 65. Middle East & Africa Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 66. Middle East & Africa Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 67. Middle East & Africa Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 68. Middle East & Africa Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 69. Saudi Arabia Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 70. Saudi Arabia Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 71. Saudi Arabia Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 72. Saudi Arabia Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 73. UAE Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 74. UAE Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 75. UAE Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 76. UAE Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 77. South Africa Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 78. South Africa Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 79. South Africa Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 80. South Africa Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 81. South and Central America Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 82. South and Central America Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 83. South and Central America Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 84. South and Central America Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 85. Brazil Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 86. Brazil Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 87. Brazil Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 88. Brazil Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 89. Argentina Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 90. Argentina Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 91. Argentina Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)
Table 92. Argentina Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 93. Recent Inorganic Growth Strategies In The Rare Neurological Disease Treatment Market
Table 94. Recent Organic Growth Strategies In The Rare Neurological Disease Treatment Market
Table 95. Glossary of Terms, Rare Neurological Disease Treatment Market
LIST OF FIGURES
Figure 1. Rare Neurological Disease Treatment Market Segmentation
Figure 2. Rare Neurological Disease Treatment, By Region
Figure 3. Global Rare Neurological Disease Treatment Market Overview
Figure 4. Alzheimer’s Disease Segment Held Largest Share Of Indication Segment In Rare Neurological Disease Treatment Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Rare Neurological Disease Treatment Market, By Geography (US$ Million)
Figure 7. Global Rare Neurological Disease Treatment Market- Leading Country Markets (US$ Million)
Figure 8. Global Rare Neurological Disease Treatment Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South and central America PEST Analysis
Figure 14. Rare Neurological Disease Treatment Market Impact Analysis Of Driver And Restraints
Figure 15. Global Rare Neurological Disease Treatment Market– Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Rare Neurological Disease Treatment Market– By Geography Forecast And Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Rare Neurological Disease Treatment Market
Figure 18. Rare Neurological Disease Treatment Market Share, by Indication, 2019 and 2027 (%)
Figure 19. Narcolepsy: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
Figure 20. Amyotrophic Lateral Sclerosis: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
Figure 21. Alzheimer’s Disease: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
Figure 22. Multiple Sclerosis: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Spinal Muscular Atrophy (SMA): Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Duchenne Muscular Dystrophy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Other Indications: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Rare Neurological Disease Treatment Market Share, by Drug Type, 2019 and 2027 (%)
Figure 27. Organic Compounds: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Biologics: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Rare Neurological Disease Treatment Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 30. Online Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Hospital Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Retail Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Rare Neurological Disease Treatment Market Share, by Mode of Administration, 2019 and 2027 (%)
Figure 34. Oral: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
Figure 35. Injectable: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
Figure 36. North America: Rare Neurological Disease Treatment Market, by Key Country – Revenue (2019) (USD Million)
Figure 37. North America Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 38. North America: Rare Neurological Disease Treatment Market, by Country, 2019 & 2027 (%)
Figure 39. US: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 40. Canada: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 41. Mexico: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 42. Europe: Rare Neurological Disease Treatment Market, by Key Country – Revenue (2019) (USD Million)
Figure 43. Europe Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 44. Europe: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
Figure 45. Germany: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. United Kingdom: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 47. France: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 48. Spain: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. Italy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. Asia Pacific: Rare Neurological Disease Treatment Market, by Key Country – Revenue (2019) (USD Million)
Figure 51. Asia Pacific Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 52. China: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. Japan: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. India: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. South Korea: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 56. Australia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 57. Middle East & Africa: Rare Neurological Disease Treatment Market, by Key Country – Revenue (2019) (USD Million)
Figure 58. Middle East & Africa Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 59. Middle East & Africa: Rare Neurological Disease Treatment Market Share by Country – 2019 & 2027, (%)
Figure 60. Saudi Arabia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 61. UAE: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
Figure 62. South Africa: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 63. South and Central America: Rare Neurological Disease Treatment Market, by Key Country – Revenue (2019) (USD Million)
Figure 64. South and Central America Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)
Figure 65. South and Central America: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
Figure 66. Brazil: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 67. Argentina: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
Figure 68. Impact of COVID-19 Pandemic In North American Country Markets
Figure 69. Impact of COVID-19 Pandemic In European Country Markets
Figure 70. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
Figure 71. Impact Of COVID-19 Pandemic In North American Country Market
Figure 72. Growth Strategies in the Rare Neurological Disease Treatment Market, 2017-2020
The List of Companies - Rare Neurological Disease Treatment Market
- Allergan plc
- Bayer AG
- GlaxoSmithKline plc
- Johnson & Johnson Services Inc
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd
- Takeda Pharmaceutical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Rare Neurological Disease Treatment Market
Mar 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Mar 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Mar 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)